Acute kidney injury and chronic kidney disease after non‐kidney solid organ transplantation

2020 ◽  
Vol 24 (6) ◽  
Author(s):  
Shina Menon ◽  
Ari H. Pollack ◽  
Erin Sullivan ◽  
Tasha Murphy ◽  
Jodi Smith
Keyword(s):  
Chronic Kidney Disease ◽  
Acute Kidney Injury ◽  
Kidney Disease ◽  
Organ Transplantation ◽  
Solid Organ Transplantation ◽  
Kidney Injury ◽  
Solid Organ

Assessment of acute kidney injury with T1 mapping MRI following solid organ transplantation

2017 ◽  
Vol 28 (1) ◽  
pp. 44-50 ◽  
Author(s):  
Matti Peperhove ◽  
Van Dai Vo Chieu ◽  
Mi-Sun Jang ◽  
Marcel Gutberlet ◽  
Dagmar Hartung ◽  
...  
Keyword(s):  
Acute Kidney Injury ◽  
Organ Transplantation ◽  
T1 Mapping ◽  
Solid Organ Transplantation ◽  
Kidney Injury ◽  
Solid Organ

Systemic Free Heme Increases the Risk for Acute Kidney Injury (AKI) after Solid Organ Transplantation

2018 ◽  
Vol 102 ◽  
pp. S463
Author(s):  
Julian Doricic ◽  
Vijith Vijayan ◽  
Andreas Leffler ◽  
Nicolas Richter ◽  
Gerrit Granas ◽  
...  
Keyword(s):  
Acute Kidney Injury ◽  
Organ Transplantation ◽  
Solid Organ Transplantation ◽  
Kidney Injury ◽  
Solid Organ ◽  
Free Heme

scholarly journals Natriuretic Peptides in the Management of Solid Organ Transplantation Associated Acute Kidney Injury: A Systematic Review and Meta-Analysis

2013 ◽  
Vol 2013 ◽  
pp. 1-7 ◽  
Author(s):  
Sagar U. Nigwekar ◽  
Hrishikesh Kulkarni ◽  
Charuhas V. Thakar
Keyword(s):  
Systematic Review ◽  
Acute Kidney Injury ◽  
Organ Transplantation ◽  
Natriuretic Peptides ◽  
Weighted Mean Difference ◽  
Meta Analysis ◽  
Solid Organ Transplantation ◽  
Kidney Injury ◽  
Solid Organ ◽  
Weighted Mean

Randomized controlled trials involving natriuretic peptide administration in solid organ transplantation setting have shown inconsistent effects for renal endpoints. We conducted a systematic review and meta-analysis of these trials to ascertain the role of natriuretic peptides in the management of solid organ transplantation associated acute kidney injury (AKI). MEDLINE, EMBASE, and Google scholar were searched independently by two authors for randomized trials evaluating renal effects of natriuretic peptides in solid organ transplantation settings. Two reviewers independently assessed the studies for eligibility and extracted the relevant data. The pooled estimate showed that natriuretic peptide administration is associated with a reduction in AKI requiring dialysis (odds ratio = 0.50 [0.26–0.97]), a statistically nonsignificant trend toward improvement in posttransplant creatinine clearance (weighted mean difference = 5.5 mL/min, [−1.3 to 12.2 mL/min]), and reduction in renal replacement requirement duration (weighted mean difference −44.0 hours, [−60.5 to −27.5 hours]). There were no mortality events and no adverse events related to natriuretic peptides. In conclusion, administration of natriuretic peptides in solid organ transplantation may be associated with significant improvements in renal outcomes. These observations need to be confirmed in an adequately powered, prospective multicenter study.

Chronic Kidney Disease After Nonrenal Solid Organ Transplantation

2012 ◽  
Vol 93 (4) ◽  
pp. 406-411 ◽  
Author(s):  
Chandrashekhar Kubal ◽  
Paul Cockwell ◽  
Bridget Gunson ◽  
Mark Jesky ◽  
Rajesh Hanvesakul ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Organ Transplantation ◽  
Solid Organ Transplantation ◽  
Solid Organ
Sign in / Sign up

Export Citation Format

Share Document